Press Releases

LifeScan Partners with Cecelia Health to Provide Personalized Diabetes Health Management Coaching for OneTouch® Consumers.

Coaching allows OneTouch consumers to have meaningful one-on-one interactions with clinicians to drive positive behavior change for people with diabetes and related conditions to live their best lives

Read the full press release.

Cecelia Health closes $13 million Series B, Rittenhouse’s Saul Richter and Endo Investors’ Eric Edidin to join board of directors, number of members now exceeds 150,000.

Read the full press release.

EY Announces David Weingard of Cecelia Health as an Entrepreneur Of The Year® 2020 New York Award Finalist.

Read the full press release.

Helmsley Awards $5 Million to Evaluate Virtual Diabetes Specialty Clinic Model.

Read the full press release.

Mellitus Health Names Steve Wubker Chief Executive Officer.

Read the full press release.

Bigfoot Biomedical® Closes Series C Financing with $55 Million as Company Readies for FDA Submission of Bigfoot Unity. Funding to Support its Breakthrough Therapy and Telemedicine Solutions for People Living with Insulin-Requiring Type 1 and Type 2 Diabetes

Read the full press release.

Bigfoot Biomedical® announces coo role and executive promotions as product launch nears. New structure readies company for anticipated launch of Bigfoot Unity™ Diabetes Management Program.

Read the full press release.

Bigfoot Biomedical® Appoints Jim Malone MD Chief Medical Officer
Recognized endocrinologist and clinical researcher joins biotech start-up as company readies for submission of its innovative approach to diabetes management.

Read the full press release.

Lilly Acquires Phase III Intranasal Glucagon from Locemia Solutions
Intranasal Glucagon Could be the First Needle-Free Rescue Treatment
for Severe Hypoglycemia.

Read the full press release.

ILiAD Biotechnologies Reports Positive Topline Results from Phase 2b Trial for Pertussis Vaccine Candidate BPZE1

Read the full press release.

ILiAD Biotechnologies Announces Presentation of Positive Phase 2b Data for Next Generation Pertussis Vaccine at World Vaccine Congress.

Read the full press release.

Diasome Announces Substantial Reductions in Level 2 Hypoglycemia Events in its Phase 2b OPTI-1 Study of Hepatocyte Directed Vesicle Technology in Type 1 Diabetes.

Read the full press release.

Diasome Announces Positive Results from Phase 2 OPTI-1 Study of Hepatocyte Directed Vesicle Technology in Type 1 Diabetes.

Read the full press release.

Trividia Health and Mellitus Health Partner to Develop Diabetes Care Products and Services for Pharmacies.

Read the full press release.

Mellitus Health and Glooko Announce Insulin-Dosing Software Integration Agreement.

Read the full press release.

Capillary Biomedical Closes $2.9 Million Series Seed Financing for
Commercialization of Novel Insulin Infusion Technology. Funding boosts development of breakthrough infusion set designed to eliminate failures and improve the quality of life for millions of diabetics

Read the full press release.